Inventor

AGRAWAL SUDHIR

US154 patents

⚠️ This page may combine multiple inventors who share the name “AGRAWAL SUDHIR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AGRAWAL SUDHIR

HYBRIDON INC

Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides

Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal

Pseudo-cyclic oligonucleobases

Mixed backbone antisense oligonucleotides containing 2&#39;-5&#39;-ribonucleotide- and 3&#39;-5&#39;-deoxyribonucleotides segments

Oligonucleotides having modified CpG dinucleosides

Inverted chimeric and hybrid oligonucleotides

Inverted chimeric and hybrid oligonucleotides

Oligonucleotide multiple reporter precursors

Method of down-regulating gene expression

Hybrid oligonucleotide phosphorothioates

Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides

Integrated oligonucleotides

Triplex-forming antisense oligonucleotides having abasic linkers targeting nucleic acids comprising mixed sequences of purines and pyrimidines

Method of down-regulating gene expression

Method of down-regulating gene expression

Method of modulating gene expression with reduced immunostimulatory response

Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides

Primary phosphoramidate internucleoside linkages and oligonucleotides containing the same

MDM2-specific antisense oligonucleotides

Synthesis of oligonucleotides containing alkylphosphonate internucleoside linkages

Process for making oligonucleotides containing o- and s- methylphosphotriester internucleoside linkages

Cyclodextrin cellular delivery system for oligonucleotides

5-pentenoyl moiety as a nucleoside-amino protecting group, 4-pentenoyl-protected nucleotide synthons, and related oligonucleotide syntheses

Method for sequencing synthetic oligonucleotides containing non-phosphodiester internucleotide linkages

Site-specific functionalization of oligodeoxynucleotides for non-radioactive labelling

Antisense oligonucleotide alkylphosphonothioates and arylphospohonothioates

WORCESTER FOUND EX BIOLOGY

Linear aminoalkylphosphoramidate oligonucleotide derivatives

Aminoalkylphosphotriester oligonucleotide derivatives

Aminoalkylphosphorothioamidate oligonucleotide deratives

Hybrid oligonucleotide phosphorothioates

Method of site-specific alteration of RNA and production of encoded polypeptides

Method of site-specific alteration of RNA and production of encoded polypeptides

Method of site-specific alteration of RNA and production of encoded polypeptides

Method of site-specific alteration of rna and production of encoded polypeptides

Inhibition of influenza virus replication by oligonucleotide phosphorothioates

Process for synthesizing oligonucleotides and their analogs adaptable to large scale syntheses

IDERA PHARMACEUTICALS INC

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

Immunostimulatory oligonucleotide multimers

Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes

Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy

UNIV MASSACHUSETTS WORCESTER

Hybrid oligonucleotide phosphorothioates

Hybrid oligonucleotide phosphorothioates

Hybrid oligonucleotide phosphorothioates

AGRAWAL SUDHIR

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

Compositions for inhibiting gene expression and uses thereof

Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments